info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

North America Drug Screening Market - by Test Sample (Urine, Blood, Hair and Saliva) by condition (Unconsciousness, Panic Attack, Chest Pain, Drug Allergies and Others)- Forecast to 2030


ID: MRFR/LS/0978-HCR | 50 Pages | Author: Rahul Gotadki| June 2024

North America Drug Screening Market Overview


The North America Drug Screening Market is projected to reach USD 6,852.8 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030

North America Drug Screening Market

Drug testing is done usually for patients who are not able to tell what kind of drugs they were taking in the past.  They are unable to tell because of various reasons for example sometime they are in a very serious condition or are unconscious. The drug testing is also used to determine allergies caused by drugs and is also used when pain management has to be done for a patient. Sometime drug testing is also done for forensic studies. This testing is done by various test samples, which includes sample like hair, saliva, blood or urine. The small amount of any one of this is collected and used for the test. There is an increase in cases of drug consumption therefore the market already has a good position. 

FIGURE:  NORTH AMERICA DRUG SCREENING MARKET SHARE BY CONDITION, 2016 (%) North America Drug Screening Market-

Study objectives of North America Drug Screening Market



  • To deliver detail study of the market structure along with projected future growth forecast for the next 7 years about various segments and sub-segments of the North America drug screening market.

  • To deliver understandings about factors affecting the market growth.

  • To study the North America drug screening market based on various factors - price analysis, supply chain analysis, Porters Five Force analysis etc.

  • To deliver past and evaluated future revenue of the market’s segments and sub-segments with respect to countries – U.S and Canada.

  • To deliver country level analysis of the market with respect to the current market size and future growth prospect.

  • To deliver country level analysis of the market’s segments which includes by test sample and by condition.

  • To deliver synopsis of key players and their strategic profiling in the market; systematically examining their core competencies and drawing a competitive landscape of the market.

  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the North America drug screening market. 



Key Companies in the North America Drug Screening market include



  • Siemens Healthnieers

  • Laboratory Corporation of America Holdings

  • Quest Diagnostics, Roche Diagnostics

  • Thermo Fisher Scientific, Inc.

  • Express Diagnostics Int'l Inc.

  • Shimadzu

  • MPD, Inc.

  • Alere Toxicology. 



Intended Audience



  • Medical device Companies

  • OEM & ODM manufacturing companies

  • R & D laboratories

  • Pathology laboratories

  • Biotechnology companies



North America drug screening market Segment Insights


The segmentation for the North America drug screening market is done on the basis of test samples and condition. The test sample segment includes hair, saliva, blood and urine. On the basis of the condition the segmentation is done into unconsciousness, panic attack, chest pain, breathing problem, vomiting, seizures, pain management, organ transplant, and drug allergies. 

North America drug screening market Regional Insights


The North America drug screening market is segmented into two countries which includes U.S and Canada. These countries have maximum number of patients who are consuming high dosage drugs for the various chronic diseases. These drugs shows various adverse effects. Thus, the market for drug testing is more in these two countries.

The report of North America drug screening market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Report Attribute/Metric Details
  Market Size   USD 6,852.8 Million
  CAGR   9.6%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered   By Test, By Condition
Geographies Covered   North America, U.S, Canada
  Key Vendors Siemens Healthnieers, Laboratory Corporation of America Holdings, Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific, Inc., Express Diagnostics Int'l Inc., Shimadzu, MPD, Inc., and Alere Toxicology.
Key Market Opportunities Increasing awareness about the impact of substance abuse on productivity and safety
Key Market Drivers The rising prevalence of substance abuse, including opioids, cannabis, and synthetic drugs.
 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.